DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+32.6%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$439M
AUM Growth
+$439M
(+5.3%)
Cap. Flow
-$48.1M
Cap. Flow
% of AUM
-10.96%
Top 10 Holdings %
Top 10 Hldgs %
49.48%
Holding
86
New
10
Increased
12
Reduced
30
Closed
14
Top Buys
| 1 |
AtriCure
ATRC
|
$4.43M |
| 2 |
Perspective Therapeutics
CATX
|
$3.69M |
| 3 |
Insulet
PODD
|
$2.73M |
| 4 |
Larimar Therapeutics
LRMR
|
$2.52M |
| 5 |
KalVista Pharmaceuticals
KALV
|
$2.44M |
Top Sells
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$15.2M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$5.74M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$5.31M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$5.25M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
$5.01M |
Sector Composition
| 1 | Healthcare | 86.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPRB
76
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| – | – |
-548,510
| Closed | -$1.61M |
|
77
VistaGen Therapeutics
VTGN
$113M
| – | – |
-41,886
| Closed | -$215K |
|
|
SAGE
78
DELISTED
Sage Therapeutics
SAGE
| – | – |
-245,000
| Closed | -$5.31M |
|
79
Oric Pharmaceuticals
ORIC
$1.03B
| – | – |
-72,797
| Closed | -$670K |
|
|
MREO
80
Mereo BioPharma
MREO
$275M
| – | – |
-778,813
| Closed | -$1.8M |
|
81
MacroGenics
MGNX
$121M
| – | – |
-152,250
| Closed | -$1.46M |
|
|
ELEV
82
DELISTED
Elevation Oncology
ELEV
| – | – |
-450,000
| Closed | -$242K |
|
83
Cullinan Oncology
CGEM
$456M
| – | – |
-127,284
| Closed | -$1.3M |
|
84
argenx
ARGX
$44.2B
| – | – |
-3,600
| Closed | -$1.37M |
|
85
Amylyx Pharmaceuticals
AMLX
$877M
| – | – |
-122,547
| Closed | -$1.8M |
|